05/15/2025 8:13 PM | Ernexa Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Ernexa Therapeutics Inc. (Subject) HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025 3:42 PM | Ernexa Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Ernexa Therapeutics Inc. (Subject) Konar Shameek (Filed by)
| Form SCHEDULE 13G | |
05/14/2025 7:39 PM | Ernexa Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Ernexa Therapeutics Inc. (Subject) IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 1:14 PM | Ernexa Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Ernexa Therapeutics Inc. (Subject) Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025 10:48 AM | Cherington Charles (Reporting) Ernexa Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Ernexa Therapeutics Inc. (Issuer)
| Form 4/A | |
04/29/2025 11:15 PM | Ernexa Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Ernexa Therapeutics Inc. (Filer)
| Form EFFECT | |
04/16/2025 3:30 PM | Ernexa Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Ernexa Therapeutics Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
04/14/2025 4:05 PM | Ernexa Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Ernexa Therapeutics Inc. (Filer)
| Form ARS | |
04/04/2025 9:54 AM | Cherington Charles (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 9:55 AM | Cherington Charles (Filed by) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
04/03/2025 4:17 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
Get the Latest News and Ratings for ERNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/03/2025 7:55 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2025 6:30 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/24/2025 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2025 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2025 3:20 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/05/2025 4:55 PM | Cherington Charles (Filed by) Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject)
| Form SCHEDULE 13D/A | |
02/14/2025 8:30 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) Singer Nicholas Jason (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 7:36 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) HALPERN JOHN D (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025 4:54 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) IAF, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025 6:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Luther Sanjeev (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Cicala Peter (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Bristol James Arthur (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 6:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Wexler William A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 4:31 PM | Eterna Therapeutics Inc. (Subject) Eterna Therapeutics (Subject) Eterna Therapeutics Inc. (Subject) Freebird Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025 4:00 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Ratner Elena (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/14/2025 4:01 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Ratner Elena (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/18/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
11/17/2024 11:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
11/14/2024 5:45 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/14/2024 5:45 AM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
11/05/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/05/2024 11:42 AM | Cherington Charles (Reporting) Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form ARS | |
09/27/2024 3:47 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form PRE 14A | |
09/27/2024 3:15 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 3:36 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Trump Predicts Dollar Downfall (Ad) READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry...
This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years."
Why Would He Say This? Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now. |
09/23/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 4:00 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:30 PM | Eterna Therapeutics Inc. (Filer) Eterna Therapeutics (Filer) Eterna Therapeutics Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024 3:32 PM | Eterna Therapeutics Inc. (Issuer) Eterna Therapeutics (Issuer) Eterna Therapeutics Inc. (Issuer) Gurrola Sandra M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |